The tissue-specific distribution of 3H-seocalcitol (EB 1089) and 3H-calcitriol in rats

Journal of Steroid Biochemistry and Molecular Biology

Volumn 89-90, Issue , 2004, Pages 43-47

  Kissmeyer, Anne Marie ^a   Nielsen, Jeanet Løgsted ^a   Binderup, Lise ^a  

^a LEO PHARMA A S   (Denmark)

Author keywords

Calcitriol; Rats; Seocalcitol EB 1089; Tissue distribution

Indexed keywords

CALCITRIOL DERIVATIVE; SEOCALCITOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; CANCER CELL; CELL ACTIVITY; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG LIVER LEVEL; DRUG STRUCTURE; HUMAN; HUMAN CELL; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; RADIOACTIVITY; RAT; TISSUE DISTRIBUTION; WHOLE BODY AUTORADIOGRAPHY;

ANIMALS; AUTORADIOGRAPHY; CALCITRIOL; MALE; RATS; TISSUE DISTRIBUTION;

EID: 3042681279     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2004.03.049     Document Type: Conference Paper

References (11)

1. DeLuca H.F., Krisinger J., Darwich H. The vitamin D system. Kidney Int. 38(Suppl. 29):1990;2-8
2. Reichel H., Koeffler H.P., Norman A.W. The role of the vitamin D endocrine system in health and disease. N. Engl. J. Med. 320:1989;980-991
3. Haussler M.R., Jurutka P.W., Hsieh J.C., Thompson P.D., Selznick S.H., Haussler C.A., Whitfield G.K. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone. Bone. 17:1995;33S-38S
4. E. Binderup, M. Calverley, L. Binderup, Synthesis and biological activity of 1α-hydroxylated vitamin D analogues with poly-unsaturated side chains, in: Proceedings of the Eighth Workshop on Vitamin D, Paris, 5-10 July 1991, pp. 192-193.
5. Colston K., MacKay A.G., James S.Y., Binderup L., Chander S., Coombes R.C. EB 1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Biochem. Pharmacol. 44:1992;2273-2280
6. Haq M., Kremer R., Golzman D., Rabbani S.A. A vitamin D analogue (EB 1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo. J. Clin. Invest. 91:1993;2416-2422
7. Mathiasen I.S., Colston K., Binderup L. EB1089 a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells. J. Steroid Biochem. Mol. Biol. 46:1993;365-371
8. K. Dalhoff, J. Dancey, L. Astrup, T. Skovsgaard, K.J. Hamberg, F.J. Lofts, O. Rosmorduc, S. Erlinger, J. Bach Hansen, W.P. Steward, T. Skov, J. Burcharth and T.R.J. Evans, A phase II study of the vitamin D analogue seocalcitol in patients with inoperable hepatocellular carcinoma (HCC), Br. J. Cancer 89 (2003) 252-257.
9. Kissmeyer A.-M., Mathiasen I.S., Latini S., Binderup L. Pharmacokinetic studies of vitamin D analogues: relationship to vitamin D-binding protein (DBP). Endocrine. 3:1995;263-266
10. Kissmeyer A.-M., Mortensen J.T. Pharmacokinetics and metabolism of a vitamin D analogue (seocalcitol) in rat and minipig. Xenobiotica. 30:2000;815-830
11. L. Binderup, E. Binderup, W.O. Godtfredsen, Development of new vitamin D analogs, in: D. Feldman, F.H. Glorieux, J.W. Pike (Eds.), Vitamin D, Academic Press, San Diego, CA, 1997, pp. 1027-1043.